Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Study Shows Medical Marijuana Reduces Chronic Pain, Opioid Use

By Kenny Walter | May 2, 2018

A new study shows that chronic pain and dependence on opioid painkillers is significantly reduced for older adults who are prescribed medical marijuana.

Researchers from Northwell Health conducted a 20-question survey of 138 individuals between 61 and 70-years-old suffering with chronic pain from osteoarthritis, spinal stenosis, hips and knees that could not be replaced and pain not relieved by steroid injections, to gauge exactly how effective medical marijuana was at managing chronic pain and reducing opioid use.

 “What I’m seeing in my practice, and what I’m hearing from other providers who are participating in medical marijuana programs, is that their patients are using less opioids,” Diana Martins-Welch, MD, a co-author of the study and physician in the Division of Geriatric and Palliative Medicine, Department of Medicine at Northwell Health, said in a statement. “I’ve even gotten some patients completely off opioids.”

Medical marijuana is only legally available in 30 states. It is also expensive, costing on average $300 for a one-month supply and not covered by insurance because it is still under a federal ban.    

The questionnaire focused on how often a patient uses marijuana, in what form they took it in, how much it reduced their pain and whether or not they were able to cut back on their use of other painkillers.

The researchers found that 18 percent of the surveyed patients decreased their use of opioids moderately, while 20 percent decreased extremely and 27 percent of the patients completely stopped the use of opioids. About 91 percent of the patients also said they would recommend medical marijuana to other patients.

“My quality of life has increased considerably since starting medical marijuana,” one patient said in an anonymous statement. “I was on opiates for 15 years, and 6 months on marijuana, and off both completely.”

Many patients, 45 percent, used vaporized oil, while 28 percent used pills and 17 percent used marijuana-laced oil. Twenty-one percent of the patients in the survey used marijuana once a day, 23 percent used it twice daily, and 39 percent used marijuana more than twice a day.

The majority of patients’ reported that their average pain scores dropped from a 9.0 on a scale of zero to 10, to 5.6 after starting marijuana.

 

Related Articles Read More >

Eli Lilly facility
9 R&D developments this week: Lilly builds major R&D center, Stratolaunch tests hypersonic craft, IBM chief urges AI R&D funding
professional photo of wooly mammoth in nature --ar 2:1 --personalize sq85hce --v 6.1 Job ID: 47185eaa-b213-4624-8bee-44f9e882feaa
Why science ethicists are sounding skepticism and alarm on ‘de-extinction’
ALAFIA system speeds complex molecular simulations for University of Miami drug research
3d rendered illustration of the anatomy of a cancer cell
Funding flows to obesity, oncology and immunology: 2024 sales data show where science is paying off
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2024 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • Call for Nominations: The 2025 R&D 100 Awards
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
    • Explore the 2024 R&D 100 award winners and finalists
  • Resources
    • Research Reports
    • Digital Issues
    • R&D Index
    • Subscribe
    • Video
    • Webinars
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE